Previous Article | Next Article 
Molecular and Cellular Biology, July 2000, p. 5064-5076, Vol. 20, No. 14
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Robust mRNA Transcription in Chicken DT40 Cells
Depleted of TAFII31 Suggests Both Functional Degeneracy
and Evolutionary Divergence
Zheng
Chen and
James L.
Manley*
Department of Biological Sciences, Columbia
University, New York, New York 10027
Received 1 March 2000/Returned for modification 10 April
2000/Accepted 27 April 2000
 |
ABSTRACT |
We have employed gene targeting coupled with conditional expression
to construct a chicken DT40 cell line in which a tetracycline (Tet)-repressible promoter is exclusively responsible for expression of
cTAFII31, a histone-like TAFII residing in both
the transcription factor TFIID and the histone acetylase complex
PCAF/SAGA. Tet addition resulted in rapid loss of cTAFII31
mRNA and protein, eventually leading to apoptotic cell death.
Significantly, five of six other TAFIIs tested were also
rapidly depleted, but levels of the TATA binding protein and subunits
of PCAF/SAGA were at most modestly compromised. Strikingly,
pulse-labeling experiments indicate that total poly(A)+
mRNA transcription was not significantly reduced after
cTAFII31 depletion, and steady-state levels of several
specific transcripts remained the same or decreased only mildly.
Moreover, activation of c-fos transcription following serum
starvation occurred efficiently in the absence of cTAFII31.
These data, which contrast with comparable studies in yeast, strongly
suggest that cTAFII31 and perhaps other TAFIIs
are not essential for general mRNA transcription in DT40 cells. We
propose that this is due to extensive functional degeneracy in the
highly complex metazoan transcriptional machinery.
 |
INTRODUCTION |
In eukaryotes, RNA polymerase II
(Pol II)-mediated mRNA transcription requires several general
transcription factors (GTFs). One important factor is TFIID, which
recognizes core promoter elements to initiate preinitiation complex
formation (45). TFIID is a multiprotein complex, consisting
of the TATA-binding protein (TBP), which is primarily responsible for
recognition of the TATA box, and approximately 10 to 12 phylogenetically conserved polypeptides called TBP-associated factors
(TAFIIs) (6, 55, 59, 62).
Early biochemical data suggested an important function of
TAFIIs in transcriptional activation (6, 62). In
reconstituted in vitro systems, TFIID, but not TBP alone, can stimulate
transcription in response to activators in the presence of other GTFs
and Pol II. Furthermore, interactions between different types of
activators and distinct TAFIIs correlated well with the
ability of the activators to enhance transcription. In light of these
data, TAFIIs were considered to be essential coactivators,
presumably functioning as the direct and specific targets of various
activators. More recently, however, TAFII-independent
activated transcription was found, under appropriate conditions, to
occur in both yeast and mammalian reconstituted systems (12, 27,
43). Moreover, additional coactivators, including PC2 and PC4,
were found to be required for TFIID-dependent transcriptional
activation in cell-free systems (7), and in a highly
purified system, PC4 can suffice for activation in the absence of
TAFIIs (68). While the coactivator function of
TAFIIs has thus not been fully established in vitro,
another line of biochemical analysis provided strong evidence for core
promoter functions of TAFIIs. Drosophila
TAFII150 was first shown to be involved in recognition of
the initiator element present in some promoters (62). A
novel core promoter element, termed downstream promoter element (DPE),
was identified in some TATA-less promoters, and this element might be
recognized by dTAFII60 and dTAFII40
(5). These additional TAFII-promoter interactions might compensate for the absence of a TATA box to allow
efficient initiation at a variety of promoters.
The function of TAFIIs has also been extensively studied in
vivo, mostly in yeast. While almost all TAFIIs studied are
essential for cell viability, genetic depletion or inactivation of
several TAFIIs appeared not to cause a significant decrease
in general mRNA transcription (39, 63). Transcription
of a subset of genes was, however, affected. Notably, depletion of
yTAFII145 effected a reduction in transcription of several
cell cycle genes, in agreement with the phenotypes of cell cycle arrest
at the G1 phase observed in both yTAFII145 and
homologous TAFII250 mutant cells (52, 57, 64,
66). In both yeast and mammals, the dependence on
yTAFII145/TAFII250 was mapped, at least in
part, to the core promoter region, suggesting a functional conservation of this TAFII. In Drosophila, a sensitized
genetic assay was utilized to provide evidence suggesting roles for
dTAFII110 and dTAFII60 in Dorsal-mediated
activation of snail gene transcription, perhaps through
direct interactions between TAFIIs and the Dorsal activator protein (70). Most recently, murine cells deprived of
TAFII30 were shown to arrest at the
G1/G0 phase, which correlated well with the
impaired expression of cyclin E in these (37). The above in
vivo data support a role for TAFIIs in transcription of
specific genes, but they do not necessarily suggest a general requirement of TAFIIs for Pol II transcription.
The possibility of a general role of TAFIIs in Pol II
transcription in yeast was further explored in a recent set of studies focusing on a group of TAFIIs known as the
histone-like TAFIIs (1, 38, 40, 42).
Several lines of evidence strongly suggest the existence of
canonical histone-fold motifs in three TAFIIs, yTAFII17/dTAFII40/42/hTAFII32/31,
yTAFII60/dTAFII62/hTAFII80, and
yTAFII61/68/dTAFII30
/hTAFII20,
which have highest sequence similarity with histones H3, H4, and H2B,
respectively (6). Inactivation of each of the histone-like
TAFIIs was shown to cause an apparent decrease in general
Pol II transcription as measured by reduced accumulation of total
and specific mRNAs. Through similar assays, yTAFII40, a
TFIID-specific TAFII, was also demonstrated to be essential
for bulk Pol II transcription (28). Additionally, a
genome-wide expression study showed that while a yTAFII145
mutation reduced expression of only 16% of genes tested, 67% required
yTAFII17 for optimal expression (22). It is
noteworthy that two earlier studies had suggested a limited role of
yTAFII60, yTAFII68, and yTAFII40 in
Pol II transcription (39, 63). Thus, while the essential
role of yTAFII17 in transcription seems firmly established, a consensus regarding these other three yTAFIIs awaits
additional studies.
The histone-like TAFIIs are also components of a histone
acetyl transferase (HAT)-containing complex, known as SAGA
in yeast (14) and PCAF in humans (44). The
discovery of TAFIIs in complexes other than TFIID
(2) has added another level of complexity to the in vivo
functions of TAFIIs: phenotypes observed after TAFII depletion could be due to TAFII function
in the context of TFIID, SAGA, or both. Supporting an important role
for SAGA in transcription, it has been found that SAGA can interact
with TBP and some acidic activators, and mutational studies of SAGA revealed transcriptional defects (54). By contrast, only a
small fraction of genes appear to be transcriptionally dependent on GCN5, the HAT activity of SAGA (22), and the
non-TAFII components of SAGA, which are not required for
viability. The exact role of PCAF/SAGA in transcriptional activation
remains to be determined.
Studies on the possible physiological functions of TAFIIs
have been carried out mostly in yeast, and it remains unclear whether higher eukaryotic TAFIIs possess similar transcriptional
and cellular functions as their yeast counterparts. To address this
question, and to resolve the controversies regarding the general
requirement for TAFIIs in activated transcription, we have
employed gene targeting coupled with conditional expression (58,
65) to construct a chicken DT40 cell line in which the only
source of cTAFII31, the homologue of yTAFII17
and dTAFII40, was from a tetracycline (Tet)-repressible
promoter. Following the addition of Tet to the culture medium,
cTAFII31 mRNA and protein were efficiently depleted, cell
growth slowed, and the cells eventually died by an apoptotic pathway.
Genetic depletion of cTAFII31 also significantly reduced the intracellular levels of several other TAFIIs, but there
were only minimal or undetectable decreases of TBP and of several
subunits of the PCAF complex. Surprisingly, 3H
pulse-labeling experiments indicate that transcription of total poly(A)+ mRNA was not significantly compromised by
cTAFII31 depletion and the abundance of several
specific transcripts was either not affected or only minimally reduced.
Taken together, these data suggest that cTAFII31 and
perhaps other TAFIIs are not universally required for
transcription in DT40 cells. We discuss these results in terms of the
existence of extensive functional degeneracy in vertebrate cells.
 |
MATERIALS AND METHODS |
Cloning of chicken TAFII31 cDNA and genomic
sequences.
Based on the dTAFII40 and
hTAFII31 sequence alignment (20), a 36-mer
oligonucleotide with 64-fold degeneracy
(5'-AACCAGMTGCTGGAGTTCRCCTTCCGITATGTIACC-3'; M, A or C; R, A or
G; I, inosine) was designed to correspond to a peptide sequence
(NQLLEFTFRYVT) from dTAFII40. This oligonucleotide was used
to screen a chicken fibroblast cDNA library (Stratagene). Out of
400,000 plaques screened, seven positives were identified and purified.
Sequence analysis of these clones revealed that they were all nearly
full length, with a poly(A) tail and a small truncation at the start of
the coding region. One cDNA clone with a truncation of only the first 3 bp (ATG) was sequenced on both strands and also used to screen a
chicken genomic DNA library (Stratagene). Fourteen positives were
purified. Southern blotting and partial sequencing of a 4.5-kb genomic
DNA fragment showed that the chicken TAFII31
gene carries seven exons comprising its coding region and 3'
untranslated region (UTR).
Cell culture and transfections.
Chicken DT40 cells were
maintained in RPMI 1640 medium (Gibco) supplemented with 10% fetal
bovine serum (HyClone) and 1% chicken serum (Sigma) at 37°C and 5%
CO2. Transfections were carried out based on the protocol
previously described (65). Thirty to forty micrograms of
each linearized plasmid was used in transfections.
Plasmid constructs.
To construct targeting vectors, the
chicken
-actin promoter-driven neomycin and hygromycin resistance
genes (65) were used to replace a BstXI fragment
spanning exon 3 to intron 5 of the chicken TAFII31 genomic
sequence. The resulting vectors were named neo-TAF and hygro-TAF,
respectively. Both constructs were linearized by BamHI
before transfection. The vector tTA, which encodes the transactivator
Tet-VP16, has been described previously (65). A
NotI site was used for linearization.
A flu-cTAFII31 cDNA that carries a Flu tag at its 5' end
and a truncated 3' UTR was inserted after the TetO-minimal promoter (13). A
-globin splicing-poly(A) sequence was inserted
downstream of flu-cTAFII31 to enhance expression
efficiency. Finally, a histidinol resistance gene (65) was
included to make the expression vector pKH(+)TFG. The expression vector
pRSET-TAF31 encoding His-tagged cTAFII31 was made by
subcloning an EcoRI-PvuII fragment that contains the full-length cTAFII31 coding region except for the start
codon into the NheI-PvuII-digested pRSET.C vector
(Invitrogen) by blunt-end ligation. A BamHI-PflMI
cTAFII31 cDNA fragment covering the Flu tag sequence and
exons 1 and 2 was ligated with
BamHI-XhoI-digested pKS(+) vector (Stratagene) to
yield the template plasmid for the 5'-end probe used in RNase
protection. The template plasmid for the deletion probe was constructed
by inserting a BstXI-ApaI cTAFII31 cDNA fragment (corresponding to most of exon 3 and part of exon 4) into
the EcoRV site of pKS(+).
Southern blotting and RNase protection assays.
Genomic DNA
purification and Southern blotting were carried out essentially as
previously described (48). Total RNA samples used in RNase
protection experiments were prepared as previously described
(9). To generate [
-32P]CTP-labeled probes,
1 µg of linearized template DNAs was transcribed in vitro by either
T3 or T7 RNA polymerase. The labeled probes were purified from 5%
polyacrylamide-8 M urea gels. For each reaction, 1 to 10 µg of total
RNA (depending on the abundance of the transcript analyzed) and 2 × 105 to 106 cpm of probe were used, following
standard protocols (48) with only minor changes. All RNase
protection assays were quantitated using a STORM Phosphorimager
(Molecular Dynamics).
Western blot analysis.
His-tagged cTAFII31 was
expressed in Escherichia coli BL21 cells transformed with
the expression vector pRSET-TAF31 following induction by
isopropyl-
-D-thiogalactopyranoside (IPTG) for 3 h
at 37°C. His-cTAFII31 was purified using Ni2+
beads under denaturing conditions according to the manufacturer's instructions (Qiagen). The protein band was excised from a preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel (17) and directly used to raise a rabbit polyclonal
antibody (Cocalico). Affinity purification was performed essentially as previously described (17). The anti-Flu monoclonal antibody (HA.11) was from Babco. The polyclonal anti-CPSF-100 antibody was
supplied by K. G. K. Murthy. Other antibodies were kindly provided by several labs (see Acknowledgments). These were all raised
against mammalian proteins, but most reacted strongly and specifically
with their chicken counterparts, and all yielded readily detectable signals.
Whole-cell lysates of DT40 cells were prepared as previously described
(
48). Protein concentrations were quantitated by
the
Bradford method (Bio-Rad) with bovine serum albumin as the
standard.
Each sample was measured in duplicate to minimize quantification
error.
Equal amounts of samples, ranging from 30 to 100 µg, were
used for
each experiment. After transfer of proteins from SDS-PAGE
gels to
nitrocellulose membranes, membranes were blocked in phosphate-buffered
saline (PBS) plus 5% milk, incubated with primary antibodies in
PBS
plus 1% milk, and washed in PBS plus 0.05 to 0.5% Tween 20.
Following
incubation with secondary antibodies, target proteins
were detected
using an ECL kit (Amersham). Membranes were routinely
stained with
Ponceau S to confirm equal
loading.
Quantitation of TAF
II31 protein levels following Tet
addition utilized both the purified anti-cTAF31 and anti-Flu
antibodies.
Specifically, Western blottings using the anti-cTAF31
antibody
revealed ~50% overexpression of cTAF
II31 in
DT40-TAF31 cells compared
with DT40 cells (see Fig.
3C), and that the
TAF
II31 levels in
DT40-TAF31 cells at 36 h after Tet
addition were

10% the amount
in DT40 cells. Extending these
findings, Western blottings using
the more sensitive anti-Flu antibody
demonstrated <5% of the zero
time concentration at 48 h
following Tet addition. After adjusting
for the different cell types
(DT40-TAF31 versus DT40), the amount
of TAF
II31 remaining
after 48 h was estimated to be ~5% the level
in DT40 cells. In
light of the further significant decrease observed
at 60 h (see
Fig.
3D), the amount of TAF
II31 was estimated to
be

2%
the amount in wild-type cells after 60 h of Tet
treatment.
Fluorescence-activated cell sorter (FACS) analysis and DNA
fragmentation assays.
One to 2 million cells were harvested. After
the medium was removed by aspiration, 300 µl of ice-cold PBS was used
to resuspend the cell pellet and the mixture was set on ice for 15 min.
Five milliliters of cold methanol was then added dropwise with gentle vortexing, followed by incubation at
20°C for at least 40 min. Cells were spun down, resuspended in 2 ml of cold PBS, and incubated for at least 20 min at 4°C before centrifugation. The pellet was resuspended in 900 µg of a PBS solution containing 60 µg of
propidium iodide (Sigma) per ml and 50 µl of RNase A per ml and
incubated for 30 min at room temperature. DNA contents were measured by a FACS Calibur (Becton Dickinson), and cell cycle profiles were analyzed by the ModFit program (Verity Software). DNA fragmentation assays were performed as previously described (21).
Pulse labeling and poly(A)+ RNA selection.
Three
to five independent pulse-labeling experiments were conducted at each
of the indicated times, and for each experiment, two cell cultures were
grown in parallel, treated or untreated with Tet (1 µg/ml; Sigma).
After incubation for the indicated time, cell densities of both
populations were adjusted to the same level, between 1 million and 1.3 million cells per ml. Appropriate splitting ratios were used so that
both cell cultures were roughly in the same growth phase when
harvested. Thirty to 35 µCi of [5,6-3H]uridine per ml
was added to each culture, and the cells were incubated for 10 to 15 min. Cells were then harvested and washed with PBS. Total cellular RNA
from both cultures were prepared (9) and checked by DE81
paper (48) to verify no contamination of unincorporated
isotope. Concentrations of RNA samples were determined by UV
adsorption. Equal amounts of total RNAs from both control and test
samples were then subjected to the following poly(A)+ RNA
selection. Typically, 20 to 40 mg of oligo(dT) cellulose (Sigma; NEB)
was packed into a 1-ml syringe to make a 100- to 150-µl column.
Isolation of poly(A)+ mRNA was conducted according to
standard protocols (48), except that samples were loaded
onto the column for four or five times over 1.5 to 2 h. Ratios of
selected RNA to total RNA for both samples were calculated after
scintillation counting of equal aliquots of each fraction. The ratio of
the control sample (without Tet), usually between 15 and 25%, was
designated 100%, while the ratio from the test sample (with Tet) was
normalized against this standard to facilitate comparisons. Selection
efficiencies of poly(A)+ RNA were measured by RNase
protection assays using a TBP cRNA as probe and typically ranged from
65 to 80%. For unusual cases in which the selection efficiency between
a test and control sample differed by 10% or more, the ratios of
selected RNA to total RNA were normalized against one another. To
measure the specificity of selection, human U6 snRNA and chicken 5S
rRNA probes were used in RNase protection assays to monitor the
distribution of poly(A)
RNAs. In most cases, the amount
of poly(A)
RNA in the poly(A)+ samples was
1% or less of the total. In accord with this, an independent assay,
ethidium bromide staining of formaldehyde RNA gels, demonstrated that
less than 1% of the 28S and 18S rRNAs was present in the
poly(A)+ samples.
Induction of c-fos transcription by serum
stimulation.
After growing in the presence of Tet (1 µg/ml) for
0, 60, or 84 h, DT40-TAF31 cells were washed once with PBS and
resuspended in serum-free RPMI media, with the addition of Tet for the
latter two time points. Following starvation for 10 h, cells were
washed and stimulated in media with 20% fetal bovine serum and 2%
chicken serum. The inclusion of Tet was as described above. Serum
stimulation lasted 75 min before harvest. At this point, cells had been
incubated in Tet-containing media for a total of 0, 72, or 96 h.
Cell cultures incubated in the presence of Tet for the same times but
not subjected to serum starvation served as controls. Total cellular
RNAs were then purified from these samples and used in RNase protection analysis. Genomic PCR was performed according to QIAGEN protocols to
amplify a chicken c-fos fragment encompassing intron 3 and part of exons 3 and 4. This c-fos probe, which is 383 nucleotides long, produced a protected fragment of 229 nucleotides.
 |
RESULTS |
Cloning and sequence analysis of cTAFII31.
To
begin a genetic analysis of cTAFII31, we first isolated the
cTAFII31 cDNA (see Materials and Methods).
Sequence analysis of purified positive clones revealed that they were
all nearly full length at around 1.3 kb with a poly(A) tail at the 3'
end. The cDNA sequence of cTAFII31 has 51 and 42%
nucleotide identity with those of hTAFII31 and
dTAFII40, respectively. The putative open reading frame
encodes a protein of 255 amino acids which, because the apparent
molecular mass of both in vitro-translated and E. coli-expressed proteins was about 31 kDa, we named
cTAFII31. Protein sequence alignments (Fig.
1A) and homology comparisons (Fig. 1B)
indicated an even greater conservation at the amino acid level. In the
N-terminal half, the histone-fold motif and the flanking region are
highly conserved from yeast to human. However, while the C-terminal
half is completely lacking in yTAFII17 and not conserved at
all (10% identity) in dTAFII40, it is almost as highly
conserved as the N-terminal half between the human and chicken
proteins. This is similar to the pattern of conservation observed with
the N-terminal "species-specific" domain of TBP (18).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
Protein sequence alignment and homology comparison of
cTAFII31. (A) Protein sequence alignment. The deduced amino
acid sequence of cTAFII31 and homologous sequences from a
human (hTAF31), Drosophila (dTAF40), and Saccharomyces
cerevisiae (yTAF17) were aligned using Clustal W software. At
those positions where at least three proteins have conserved residues,
amino acids are outlined black (identical) or gray (similar). (B)
Evolutionary conservation between homologous sequences. A schematic
representation of the homologues is shown, with percent identities
compared to the human protein indicated. The positions of the
histone-fold motif (HFM), the flanking conserved region (CR), and the
C-terminal nonconserved region (TAIL) are shown.
|
|
Construction of a cTAFII31 conditional knockout DT40
cell line.
Chicken DT40 cells can undergo homologous recombination
at a high frequency, making them ideal for gene-targeting studies (58, 65). Genomic Southern analysis indicated that
cTAFII31 is a single-copy gene in DT40 cells
(data not shown). A cDNA probe was used to isolate a 4.5-kb genomic
clone. Partial sequencing revealed that this fragment contained at
least seven exons from the coding region and 3' UTR (Fig.
2A). BstXI digestion was used to delete exons 3 to 5, corresponding to most of the histone-fold motif
and flanking conserved region, and either of two drug selection markers, neomycin or hygromycin resistance, was inserted into the
digested plasmid to produce the targeting vectors neo-TAF31 and
hygro-TAF31, respectively. DT40 cells were first transfected with
neo-TAF31. Southern blotting of DNA from drug-resistant colonies (Fig.
2B) revealed that ~20% of the clones had an 8.4-kb band, as expected
from homologous recombination. Transfection of hygro-TAF31 into DT40
cells also gave rise to an ~20% homologous recombination efficiency.
However, transfection of either type of heterozygous cell line with the
reciprocal targeting vector failed to produce any double-allele
knockout cells (data not shown), suggesting that cTAFII31
is essential for DT40 cell viability.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 2.
Disruption of the cTAFII31 gene
in DT40 cells. (A) Genomic organization and targeting vectors. The
structure of the cTAFII31 gene is shown, along
with the two targeting vectors used to disrupt both wild-type alleles.
The black boxes represent exons. In both targeting vectors, selection
marker genes (neo or hygro, gray boxes) replace exons 3 through 5. Positions of relevant restriction sites (Bx, BstXI; X,
XhoI; H, HindIII; E, EcoRI) and
the direction of transcription (arrows) are indicated. The flanking
region probe (HindIII-EcoRI fragment) and the
sizes of the relevant fragments are also denoted. (B) Southern blot
analysis. Genomic DNA was purified from wild-type DT40 cells (WT),
heterozygous cells transfected with hygro-TAF (hygro) or neo-TAF (neo)
targeting vectors, or homozygous cells after the second round of
transfections (TAF31). After digestion with EcoRI, DNAs were
subjected to Southern blot analysis using the probe depicted above.
Positions of wild-type (WT) or targeted fragments (neo and hygro) are
indicated.
|
|
To disrupt the second allele and introduce instead a conditional
version of the
cTAFII31 gene, we adopted the
Tet-repressible
expression system as described by Wang et al.
(
65). As a preliminary
experiment, we first constitutively
expressed Flu epitope-tagged
cTAF
II31 driven by the

-actin promoter in a hygromycin-resistant
heterozygous cell line.
Subsequent transfection of these cells
with neo-TAF31 indeed gave rise
to double-knockout cells (data
not shown), establishing the ability of
flu-cTAF
II31 expressed
from a strong constitutive promoter
to substitute for the endogenous
protein. To establish a
Tet-repressible allele, we cotransfected
hygromycin-resistant
heterozygous cells with a construct encoding
the chimeric
transactivator tetR-VP16 (tTA) and an expression
vector encoding
Flu-tagged cTAF
II31, driven by a Tet-responsive
promoter.
Drug-resistant colonies were screened by RNase protection,
using the 5'
probe depicted in Fig.
3A. Several clones
expressing
high levels of flu-cTAF
II31 transcripts were
selected and transfected
with the neo-TAF31 construct. Almost 100 drug-resistant clones
were screened by Southern blotting, but only one,
called DT40-TAF31,
was found to have targeted the second allele (Fig.
2B). The reason
for this low targeting efficiency is unknown.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of cTAFII31 in DT40-TAF31 cells.
(A) RNase protection assay using a 5'-end probe. Ten micrograms of
total RNAs from DT40 cells (WT), heterozygous cells (HET), and
DT40-TAF31 cells incubated in the presence of Tet (1 µg/ml) for the
indicated times was analyzed by RNase protection. The Flu tag sequence
accounts for the size difference between endogenous and exogenous
expression. tRNA was used as a negative control. (B) RNase protection
assay using a deletion probe. The probe corresponds to part of the
region deleted during gene targeting events (diagrammed below). Assay
conditions are as above. The position of a background band, which is
also present in the tRNA control lane, is indicated by an asterisk. (C)
Western blot analysis using an affinity-purified polyclonal
anti-cTAFII31 antibody. (Top) Thirty micrograms of total
cellular proteins from wild-type, heterozygous, DT40-TAF31, and
DT40-actin-TAF31 cells that was fractionated on an SDS-10% PAGE gel,
transferred to a nitrocellulose membrane, and probed with an
anti-chicken TAFII31 polyclonal antibody. Positions of
flu-cTAFII31 and cTAFII31 are shown. (Bottom)
The indicated amounts of total cell proteins from wild-type or
DT40-TAF31 cells were analyzed as shown in the top panel. (D) Western
blot of time course of Tet-induced depletion. DT40-TAF31 cells were
incubated in the presence of Tet (1 µg/ml) for the indicated times
before harvest. Lysates prepared from these cells were analyzed for
Tet-repressible expression of flu-cTAFII31 using the above
anti-cTAFII31 antibody (upper panel), a monoclonal antibody
against the Flu tag (middle panel), and a polyclonal antibody against
CPSF-100 (lower panel). Wild-type cell lysates (WT) were analyzed for
comparison.
|
|
We next determined how effectively cTAF
II31 mRNA synthesis
could be repressed by Tet. The response of cTAF
II31 mRNA
expression
to Tet was measured by RNase protection, first using the
same
probe as above (Fig.
3A). Heterozygous cells expressed slightly
less cTAF
II31 mRNA than did wild-type cells, possibly
reflecting
the loss of one allele (Fig.
3A and B, compare lanes WT and
HET).
DT40-TAF31 cells expressed flu-cTAF
II31 mRNA at a
much higher
level in the absence of Tet (time point 0). In the presence
of
Tet, however, the amount of this mRNA was dramatically reduced,
becoming undetectable after 24 h. Note that the protected band
from the endogenous allele was still present in DT40-TAF31 cells,
likely reflecting expression of a 5' fragment of TAF
II31
mRNA.
This was confirmed by using a probe from the center of the gene,
which revealed only Tet-repressible TAF
II31 mRNA (Fig.
3B).
We next examined cTAF
II31 protein expression by Western
blotting, first using an affinity-purified anti-cTAF
II31
polyclonal
antibody (Fig.
3C). Levels of cTAF
II31 were
reduced ~2-fold in
the heterozygous cells, consistent with the loss
of one
cTAFII31 allele and the absence of a
positive autoregulatory mechanism
to compensate. In contrast,
flu-cTAF
II31 accumulated to levels
slightly higher than did
cTAF
II31 in DT40 cells (~1.5-fold; Fig.
3C, bottom) in
both DT40-TAF31 cells and a cTAF
II31 knockout cell
line
with constitutive expression of flu-cTAF
II31
(DT40-actin-TAF31).
This contrasts with the much greater overexpression
of the mRNA
and suggests a posttranscriptional regulatory mechanism to
limit
cTAF
II31 accumulation. We next followed the fate of
flu-cTAF
II31
after addition of Tet, using both the
affinity-purified antibody
and a sensitive anti-Flu monoclonal antibody
(Fig.
3D and results
not shown). Only low levels of
cTAF
II31 (

10% the amount in DT40
cells) were detectable
after a 36-h incubation in Tet, and the
protein was undetectable by
60 h, even after extended exposures
(

2% the amount in wild-type
cells, determined by comparisons
with diluted extracts using both the
purified anti-cTAF
II31 and
anti-Flu antibodies; see
Materials and Methods for details). Incubation
in a 10-fold-higher
concentration of Tet did not significantly
affect cTAF
II31
depletion efficiency (data not shown). The level
of the 100-kDa subunit
of polyadenylation factor CPSF (Fig.
3D)
and Coomassie blue-stained
protein profiles (data not shown) were
unchanged by Tet. Taken
together, these results demonstrate that
exogenous
flu-cTAF
II31 can functionally replace the endogenous
protein and that this expression displayed a sensitive and rapid
response to
Tet.
Depletion of cTAFII31 induces apoptosis, but not
specific cell cycle arrest.
Almost all TAFIIs tested
so far are essential for cell survival (30). To provide
additional evidence for the essential role of cTAFII31 in
DT40 cells, we examined cell growth in the presence of Tet (Fig. 4A and
B). Cells
grew normally until 48 h after Tet addition but began to grow more
slowly thereafter. After 84 h, cell growth ceased and the number
of viable cells began to decline. A 10-fold-lower concentration of Tet
was also sufficient to elicit cell death, although somewhat more slowly
(not shown). These results strongly suggest that expression of at least
one gene required for viability is dependent on cTAFII31.
We next examined additional morphological properties of the Tet-treated
cells. First, membrane blebbing was observed in the cell population
treated with Tet (data not shown), suggesting that cell death may
involve an apoptotic pathway. To investigate this, as well as any
possible effects on cell cycle progression, we performed FACS analysis
to measure the DNA content of DT40-TAF31 cells incubated with Tet for
different periods of time (Fig. 4C). To eliminate potential effects of
cell growth phase on this analysis, cell populations were split at different ratios so that cells grown in the absence or presence of Tet
were at similar densities when harvested (see Fig. 4B). In the absence
of Tet, cells had essentially the same cell cycle profile throughout
the time course, shown here at 0, 48, and 96 h. Cells incubated
with Tet displayed this pattern until ~60 h, after which increases in
the sub-G0/G1 fraction, indicative of DNA
fragmentation, could be detected. The sub-G0/G1
fraction constituted nearly 85% of the population by 120 h.
Consistent with the FACS results, direct visualization of DNA by
agarose gel electrophoresis revealed accumulation of nucleosome
ladder-sized fragments at 72- and 96-h time points (results not shown).


View larger version (64K):
[in this window]
[in a new window]
|
FIG. 4.
Depletion of cTAFII31 causes apoptic cell
death. Shown are growth curves of DT40-TAF31 cells split at low (A) or
high (B) densities. DT40-TAF31 cells were passaged into medium with or
without Tet (1 µg/ml), and the concentration of cells at the
indicated times was determined by hemacytometer counting. (C) FACS
analysis. DNA content of DT40-TAF31 cells, cultured in the absence of
Tet for 0, 48, and 96 h or in the presence of Tet (1 µg/ml) for
24, 48, 72, 96, 120, and 144 h exactly as shown in panel B, was
analyzed by FACS Calibur (Becton Dickinson). (Cells grown in the
absence of Tet for 48 h were analyzed prior to passage.) Different
phases of the cell cycle are indicated in each diagram. x
and y axes represent DNA content and cell number,
respectively.
|
|
Previous studies have identified specific cell cycle arrest phenotypes
after inactivation of yTAF
II145/TAF
II250,
yTAF
II150
(TSM), yTAF
II90, and murine
TAF
II30 (reference
37 and references
therein). In contrast, similar to the behavior of yTAF
II17
(
1),
depletion of cTAF
II31 did not lead to a
specific cell cycle arrest
(Fig.
4C), as the profile of cell cycle
stages remained similar
as late as 72 h after Tet addition.
However, at later time points,
a relative increase in the percentage of
G
2/M cells was observed.
By 120 and 144 h of Tet
incubation, when most cells were dead,
the great majority of living
cells possessed a characteristic
G
2/M-phase DNA content
(Fig.
4C). Since this accumulation of G
2/M
cells was only
seen at later stages when most cells were undergoing
apoptosis, and
also because the absolute number of G
2/M cells
at these
time points remained roughly the same, it is unlikely
that this
reflected a specific cell cycle arrest. An alternative
explanation is
that G
2/M cells were resistant to apoptosis. An
inhibitor
of apoptosis, survivin, was recently found to be expressed
specifically
in the G
2/M phase and may help to negate an M
phase-specific
apoptotic pathway (
31). Whether such an
antiapoptotic pathway
is operative in DT40 cells is unclear, but in any
event, our data
show that depletion of cTAF
II31 results in
apoptotic cell death,
but not cell cycle
arrest.
Differential effects of cTAFII31 depletion on
accumulation of TFIID and PCAF subunits.
TAFII31 is a
component of at least two multisubunit complexes, TFIID and PCAF/SAGA.
We therefore next determined the influence of cTAFII31
depletion on accumulation of other subunits of these complexes. It has
been suggested that TAFII31, together with two other
histone-like TAFIIs, TAFII80 and
TAFII20, forms a nucleosomal octomer-like subcomplex that
may be important for TFIID structural integrity (6). Upon
depletion of one of the histone-like TAFIIs, the subcomplex
would disassociate, thereby destabilizing TFIID. The amount of the
resulting free subunits, including histone-like TAFIIs and
other TAFIIs, would be downregulated, possibly by protein degradation. Evidence consistent with this has been reported for yeast
(1, 38, 40, 42). We therefore examined levels of a number of
TAFIIs by Western blotting following addition of Tet to
DT40-TAF31 cells (Fig. 5A and C).
Strikingly, nearly all showed rapid and significant decreases. These
include not only TAFII80 and TAFII20 but also
TAFII250, TAFII55, and TAFII30. All
showed decreased accumulation as early as 12 h after Tet addition
and were depleted on the order of 80% after 60 h. Among the
TAFIIs tested, only TAFII100 was unaffected
throughout the time course. Why this one TAFII was stable
is not clear, although it is of interest that this WD-40
repeat-containing protein is thought to help anchor the histone-like
TAFIIs into the TFIID complex (60). Importantly,
the levels of TBP decreased only slightly (~2-fold) throughout the
time course (Fig. 5B).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 5.
Immunoblot analysis of subunits of TFIID and PCAF
complexes. DT40-TAF31 cells were cultured in the presence of Tet for
the indicated time before harvest. Total lysates were prepared and
quantitated by the Bradford method. Equal amounts of lysates were
fractionated on SDS-PAGE gels and probed with antibodies directed
against the indicated proteins. Lysates from wild-type DT40 cells (WT)
were analyzed for comparison. (A) TFIID-specific subunits. (B) TBP. (C)
Subunits common to TFIID and PCAF. (D) PCAF-specific subunits.
|
|
Previous studies have also suggested a structural role for several
TAF
IIs in the SAGA complex (
14,
38,
42), which
prompted
us to investigate the effect of cTAF
II31 depletion
on subunits
of the SAGA/PCAF complex. As noted above, in addition to
cTAF
II31,
another TAF
II common to both
complexes, TAF
II20, was significantly
reduced in
concentration (Fig.
5C). In sharp contrast, all other
PCAF subunits
tested showed, at most, modest reductions (Fig.
5D). Levels of PCAF
itself and the related GCN5-S protein, both
of which contain HAT
activity, were reduced at most very slightly,
less than twofold. The
TAF
II100-like factor, PAF65

, was not affected
at all,
consistent with the behavior of TAF
II100. Another subunit,
Ada3, was also only minimally depleted. Taken together, these
results
suggest that depletion of cTAF
II31 exerted a severe effect
on the integrity of TFIID, but only slightly affected components
of the
PCAF
complex.
cTAFII31 is not universally required for Pol
II-mediated transcription.
The apparent disruption of TFIID caused
by cTAFII31 depletion, as well as the reported deleterious
effects of yTAFII17 inactivation on total Pol II
transcription, suggested that addition of Tet to DT40-TAF31 cells would
result in a rapid inhibition of Pol II transcription. To test this, we
first performed pulse-labeling experiments to measure total
transcription activity at different times after Tet addition to
DT40-TAF31 cells. Pulse labeling allows a measure of ongoing
transcription at the time of the pulse and is thus preferable to
methods that measure total accumulated mRNA, in which mRNA turnover may
complicate interpretations.
Cells were split as shown in Fig.
4B to ensure that transcription was
not influenced by any differences in cell growth state
between the
control (without Tet) and test samples (with Tet).
Equivalent numbers
of cells were labeled with [
3H]uridine by short pulses
(10 to 15 min) at the times indicated
in Fig.
6. Equal amounts of total RNA purified
from labeled cells
were then subjected to oligo(dT) selection to
isolate poly(A)
+ mRNA. The efficiency and selectivity of
the protocol were verified
as described in Materials and Methods. The
poly(A)
+ RNA fraction routinely contained 3 to 5% of total
RNA (measured
by optical density at 260 nm) and 15 to 25% of the total
pulse-labeled
RNA. Importantly, 1% or less of the
poly(A)

RNA (e.g., rRNA) was detected in the
poly(A)
+ samples, and the amounts of total RNA and mRNA
purified from
equal numbers of cells grown in Tet
+ and
Tet

media were equivalent at all time points up to
60 h. The yield
of total RNA from the cells grown in Tet decreased
slightly at
72 and 96 h, although the relative amounts of
poly(A)
+ and poly(A)

RNA were unchanged. This
likely reflected the inclusion of dead
or dying cells at these times.
The ratio of
3H incorporation of the selected
poly(A)
+ population against that of total RNA was
calculated for both
control and test samples, and values from the
control samples
were all set at 100% to facilitate comparisons.
Results from the
indicated time points, each representing three to five
independent
experiments, are shown in Fig.
6. Strikingly,
poly(A)
+ RNA synthesis was unaffected as late as 60 h
after Tet addition,
a time at which cTAF
II31 was
undetectable and other TFIID components
were significantly depleted
(Fig.
5). Even at 72 h, just a minimal
(8%) decrease was
detected. Only at 96 h, when a large fraction
of the cell
population was undergoing cell death, was a significant
decrease (25%)
in poly(A)
+ RNA synthesis observed. These data suggest that
total Pol II
transcription was not influenced to a significant degree
by depletion
of cTAF
II31 and apparent disruption of TFIID.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Pulse-labeling analysis of general Pol II-mediated
transcription in DT40-TAF31 cells. DT40-TAF31 cells were cultured in
medium with or without Tet for the indicated times. Each culture was
pulse labeled with [3H]uridine for 10 to 15 min. Total
cellular RNAs were purified, and poly(A)+ RNA was selected
on an oligo(dT) column. The ratios of selected poly(A)+ RNA
to total RNA were determined after scintillation counting of equal
aliquots of each sample. The ratios for control samples (cells grown in
the absence of Tet [ ]) were designated 100%, and the ratios for
test samples (cells grown in the presence of Tet [+]) are presented
relative to this. Results from three to five independent experiments
for each of the indicated time points were averaged and plotted. Error
bars represent standard deviation.
|
|
To explore further the consequences of cTAF
II31 depletion
on mRNA synthesis, we examined the abundance of a number of specific
transcripts by RNase protection (Fig.
7).
These mRNAs differ significantly
in their structures, functions,
abundance, half-lives, and expression
profiles during B-cell
development (Fig.
7A). Consistent with
the pulse-labeling results,
levels of four different mRNAs, encoding
TBP, Tra2

, histone 2B and
immunoglobulin M (IgM) L chain (the
most abundant transcript in DT40
cells; e.g., 58), remained essentially
unchanged, even at 96 h
after Tet addition. Two other transcripts,
encoding

-actin and IgM H
chain, were slightly decreased (two-
to threefold) at later time
points. Interestingly, these two mRNAs,
but not the others tested,
showed differences in their abundance
in DT40 cells compared to that in
DT40-TAF31 cells in the absence
of Tet, with actin levels two- to
threefold higher in the mutant
cell line and H chain decreased by
three- to fivefold (Fig.
7A).
Although the reason for this is unknown,
it may reflect the altered
level of cTAF
II31 in the
knockout cells (Fig.
3C). As expected,
accumulation of 5S rRNA and
U6 snRNA (RNA Pol III dependent) was
not affected by
cTAF
II31 depletion (Fig.
7B).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 7.
RNase protection analysis of steady-state levels of
specific transcripts. Total cellular RNA was isolated from wild-type
DT40 and DT40-TAF31 cells incubated in the presence of Tet for the
indicated times. Equal amounts of total RNAs for each sample were
hybridized with [32P]CTP-labeled probes. After RNase
digestion, the protected bands were separated on polyacrylamide gels.
(A) Expression levels of six Pol II transcripts. (B) Expression of 5S
rRNA and U6 snRNA.
|
|
The above assays measure primarily ongoing transcription of genes
constitutively expressed in DT40 cells. We next wished to
determine
whether an inducible gene could be activated in the
absence of
cTAF
II31. To this end, we examined induction of the
c-
fos gene in response to serum stimulation following serum
starvation.
The rapid induction of c-
fos transcription as a
result of various
extracellular signals has been well characterized and
involves
the formation of a ternary protein-DNA complex
(
61). As shown
in Fig.
8,
during a time course of up to 96 h of incubation in
Tet,
c-
fos transcript synthesis in cells serum starved for
10
h was efficiently induced by a short period (75 min) of serum
stimulation regardless of the time of Tet incubation (Fig.
8,
compare
lanes 4 and 6, in Tet for 72 and 96 h, respectively, to
lane 2, without Tet). By contrast, cells not subjected to serum
starvation
expressed essentially undetectable levels of c-
fos mRNA
during the same Tet incubation periods (see lanes 1, 3, and
5). As
controls, cTAF
II31 expression was indeed abrogated during
the time course and TBP mRNA expression remained constant and
was
unaffected by serum treatment (Fig.
8). Therefore, after
cTAF
II31
had been totally depleted from the cells,
inducible transcription
of c-
fos in response to serum
stimulation was not compromised.
Taken together, our experiments
strongly suggest that cTAF
II31
is not essential for high
levels of Pol II-mediated transcription
of many genes in chicken DT40
cells.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 8.
RNase protection analysis of serum-induced
c-fos expression. Total cellular RNA was isolated from
DT40-TAF31 cells incubated in the presence of Tet for the indicated
times, with or without 10 h of serum starvation and 75 min of
serum stimulation. Equal amounts of total RNAs for each sample were
analyzed by RNase protection using c-fos,
cTAFII31, or TBP probes, and the protected bands were
separated on polyacrylamide gels.
|
|
 |
DISCUSSION |
In this study, we established a conditional TAFII31
knockout cell line in chicken DT40 cells. Unexpectedly, results from
[3H]uridine pulse-labeling experiments illustrated that a
high level of Pol II-mediated transcription occurred in the apparent
absence of cTAFII31 and reduced levels of several other
TAFIIs. In agreement with this, the transcript levels of
several specific genes were unchanged or decreased only modestly, even
as the cells began to undergo extensive cell death. Importantly, while
in yeast the expression of TBP, histone 2B, and actin mRNAs was reduced
in a yTAFII17 mutant strain by 3.1-, 3.7-, and 6.2-fold,
respectively (22), chicken TBP and histone 2B maintained the
same expression level well after complete cTAFII31
depletion, and
-actin expression exhibited only a minimal reduction
at later time points. On a global scale, ongoing differential display
experiments also reveal comparable expression of a large majority of
genes with or without cTAFII31 (unpublished data).
Furthermore, cTAFII31 is also dispensable for the efficient
induction of c-fos transcription, indicating that a
transcriptionally silent gene can be activated in the absence of
cTAFII31. These results strongly suggest that
cTAFII31 is not an essential general coactivator for class
II gene transcription and that transcription of many genes can continue
unabated in the presence of significantly reduced levels of several
TAFIIs.
The observed modest effect on transcription by cTAFII31
depletion is, on the one hand, surprising in light of previous studies on yTAFII17, but in retrospect is not inconsistent with
several studies analyzing other metozoan TAFIIs. For
example, the hamster cell line harboring a weak temperature-sensitive
mutant of TAFII250 was shown to be defective in expression
of some, but not all, genes tested at the nonpermissive temperature
(57, 66), consistent with subsequent experiments on yeast
TAFII145 (52, 64). In Drosophila, a
weak, nonlethal mutation in dTAFII40, identified in a
genetic screen for regulatory genes involved in pigmentation, as well
as dominant modifier mutants of dTAFII60 and
dTAFII110, conferred selective transcriptional defects
(51, 53, 70). Recently, an approach similar to that used
here was employed to target TAFII30 in murine F9 cells
(37). Human TAFII30 is found in only about 50%
of TFIID complexes (24) and thus may be considered a
specific TAFII, but it is also present in PCAF/SAGA and
TFTC (see below) complexes (14, 44, 67). Depletion of
TAFII30 resulted in cell death, but did not appear to have
a general effect on transcription, which could have been indicative of
either its specific role and/or the fact that the levels of other
TAFIIs examined were not affected. Surprisingly, a
temperature-sensitive mutant of yTAFII25, the
TAFII30 homologue, has been reported to display a strong
general transcription defect at the nonpermissive temperature, perhaps
reflecting the fact that multiple other TFIID and SAGA components were
codepleted (49). Unlike yTAFII17, genome-wide analysis is currently not available to substantiate the broad requirement of yTAFII25 in transcription. Taken together,
these studies are consistent with the view that metazoan
TAFIIs are necessary for transcription of specific genes,
but for different reasons they did not resolve the question of whether
they are generally required for transcription in vivo.
Another line of in vivo evidence was provided by studies of TBP
recruitment in yeast using chromatin immunoprecipitation procedures (29, 32). It was shown that activator-dependent
transcription correlated well with the loading of TBP and that this TBP
binding required general factors on a majority of promoters tested, but yTAFII145 enhanced TBP binding only on specific promoters.
Further insight into the role of TAFIIs in TBP recruitment
was offered by quantitation of transcriptional factors in cells
(26, 30). In both yeast and HeLa cells, the reservoir of
GTFs, including TBP, is estimated to be almost 10-fold greater than
that of TAFIIs. Additionally, only a fraction (~15%) of
the TBP bound to chromatin appears to be associated with the
TFIID-specific hTAFII100 (26). Taken together,
these findings invoke the possibility that TAFIIs might
assist TBP recruitment to only a subset of promoters. A number of more
recent in vitro studies have also provided corroborative biochemical
evidence for the above in vivo studies (33), consistent with
a possible gene-specific, rather than global, role of
TAFIIs in transcription.
Our results extend these previous studies in several important ways.
First, our experiments are the first in a metazoan system to inactivate
completely one of the histone-like TAFIIs, which are
believed to play important structural roles in TFIID (6) and, especially yTAFII17, to be generally required for
transcription in yeast (1, 38, 40). Second, ours is the only
study performed in higher eukaryotes in which the levels of
TAFIIs in addition to the targeted TAFII were
significantly reduced. In yeast, this is thought to be characteristic
of tight conditional mutants, and it has been suggested that only such
tight mutants display global transcriptional defects (28,
38). By the criteria of the rapid shut-off of
cTAFII31 expression following Tet addition, in addition to
the significant codepletion of other TAFIIs, DT40-TAF31 cells have the characteristics of a tight mutant. Finally, to our
knowledge, ours is the first analysis of TAFII function in any organism to measure transcription directly, i.e., by pulse labeling, as opposed to measurements of steady-state mRNA. Although such measurements likely do reflect transcription, it is not impossible that apparent reductions in mRNA may in some cases reflect enhanced mRNA turnover, perhaps as a direct effect of TAFII
depletion, given recent experiments linking mRNA capping (8, 35,
69) and polyadenylation (11, 19, 36) to transcription.
In any case, our experiments provide the most compelling evidence to date that TAFIIs are not essential for activated
transcription in higher eukaryotes and, as discussed below, suggest the
existence of important functional redundancies in metazoans, as well as significant differences between yeast and vertebrate transcriptional mechanisms.
Depletion of cTAFII31 resulted in specific decreases in the
concentrations of multiple TAFIIs, but did not
significantly affect accumulation of other proteins. Importantly, the
levels of TBP and several subunits of PCAF were much less sensitive to
the absence of cTAFII31. In the case of PCAF/SAGA, this
might stem from the fact that this complex is much bigger than TFIID,
and its more than 20 subunits appear to be organized into several
subcomplexes that might possess a certain degree of functional and
structural autonomy (15). Previously, a
temperature-sensitive mutant of yTAFII60 has been reported
to lead to only a mild structural change upon temperature shift and the
smaller SAGA complex still retained partial HAT activity
(14). Another study has implied that three non-TAFII subunits constitute the structural core of the
SAGA complex (54). Our results are consistent with this and
further suggest that the integrities of the TFIID and PCAF/SAGA
complexes are differentially affected by removal of
TAFII31.
How could it be that transcription is not generally affected by
complete removal of TAFII31 and significant depletion of
several other TAFIIs? The answer, we suggest, involves
extensive functional degeneracy. Recent years have witnessed the
discovery of much greater complexity within the transcription machinery
than previously conceived. For example, a number of variant forms of
TFIID and RNA Pol II holoenzyme have been identified in yeast and human (2). A group of TAFIIs, most notably the
histone-like TAFIIs, were also found to be components of
various TBP-free HAT complexes, including SAGA/PCAF and another similar
complex called TFTC (2, 16, 55, 67). Another
TAFII31-containing complex contains a novel long form of
GCN5 and Spt3, but is devoid of other histone-like TAFIIs
(3, 34). Other than TAFIIs, many protein factors
or complexes can function as coactivators, including a rapidly growing family of multifunctional chromatin-remodeling activities, such as HATs
and ATP-dependent activities (25, 30). Recently, a number of
cofactor protein complexes were identified biochemically, such as CRSP
as a coactivator to Sp1 (47) and four essentially identical
complexes (TRAP, ARC, SMCC, and DRIP) with diverse functional activities (23, 41, 46). All five complexes have with two other complexes (4, 56) common subunits corresponding to yeast SRB/mediator proteins. These burgeoning multifunctional coactivator families, together with previously proposed USA fractions, TFIIA, and TAFIIs, may form a balanced yet flexible
cofactor network. In DT40-TAF31 cells depleted of TAFIIs,
the remaining large TBP pool can still perform
TAFII-independent functions, and other cofactors, such as
the partial PCAF complex and/or other coactivators, can, we suggest,
substitute for the missing TAFIIs on many promoters that
naturally utilize TFIID. It is also possible that in the TAFII31-depleted cells, the low levels of the remaining
TAFIIs reflect partial TFIID complexes that are selectively
associated with active genes.
Our results suggest that cTAFII31 is required for only a
subset of class II gene transcription in chicken. This contrasts sharply with the situation in yeast, in which yTAFII17 is
the only yTAFII whose essential role in Pol II
transcription is universally supported by various experimental
approaches. One explanation for this apparent inconsistency is that the
functional degeneracy we suggest to be in vertebrates is absent in
yeast. In support of such an evolutionary divergence, numerous examples
of transcription factors present in metazoans but lacking in yeast have
been uncovered in recent years, including TBP-related factors in higher
eukaryotes (11), three mammalian proteins homologous to
yGCN5, and TAFII80- and TAFII100-like factors
in the PCAF complex (44). Half of the subunits of TRAP
identified thus far are missing from the yeast genome (23).
Following the same combinatorial principle as in mediator-containing
complexes, the number of cofactor complexes would grow exponentially in
order to cope with the multitude of metazoan-specific activators and
much more complicated developmental and tissue-specific gene regulatory
programs (50). As a consequence of such finely tuned gene
regulation, however, a large number of factors would function in the
same pathway, perhaps in the same step, raising the possibility of much
greater functional degeneracy in metazoans than in yeast, with its
simpler genetic circuitry. Thus, while yTAFII17 appears to
be broadly required for transcription of many yeast genes, in higher
eukaryotes the absence of TAFII31 might be compensated for
on most, but not all, genes by other factors. It is interesting to
speculate that such metazoan-specific functional degeneracy might exist
in other complex regulatory pathways.
 |
ACKNOWLEDGMENTS |
We thank Y. Nakatani, R. Tjian, R. Roeder, L. Tora, C.-M. Chiang,
and K. G. K. Murthy for kindly providing antibodies. We are
grateful to Y. Takagaki, T. Kashima, M. Um, and S. Valadkhan for gifts
of template DNAs for RNase protection assays. We thank members of
Manley's and Prives' labs for helpful discussions. We also thank Inna
Boluk for helping prepare this paper.
This work is supported by NIH grant GM 37971.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Sciences, Columbia University, New York, NY 10027. Phone: (212) 854-4647. Fax: (212) 865-8246. E-mail:
jlm2{at}columbia.edu.
 |
REFERENCES |
| 1.
|
Apone, L. M.,
C. A. Virbasius,
F. C. Holstege,
J. Wang,
R. A. Young, and M. R. Green.
1998.
Broad, but not universal, transcriptional requirement for yTAFII17, a histone H3-like TAFII present in TFIID and SAGA.
Mol. Cell
2:653-661[CrossRef][Medline].
|
| 2.
|
Bell, B., and L. Tora.
1999.
Regulation of gene expression by multiple forms of TFIID and other novel TAFII-containing complexes.
Exp. Cell Res.
246:11-19[CrossRef][Medline].
|
| 3.
|
Birck, C.,
O. Poch,
C. Romier,
M. Ruff,
G. Mengus,
A. C. Lavigne,
I. Davidson, and D. Moras.
1998.
Human TAF(II)28 and TAF(II)18 interact through a histone fold encoded by atypical evolutionary conserved motifs also found in the SPT3 family.
Cell
94:239-249[CrossRef][Medline].
|
| 4.
|
Boyer, T. G.,
M. E. Martin,
E. Lees,
R. P. Ricciardi, and A. J. Berk.
1999.
Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein.
Nature
399:276-279[CrossRef][Medline].
|
| 5.
|
Burke, T. W., and J. T. Kadonaga.
1997.
The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila.
Genes Dev.
11:3020-3031[Abstract/Free Full Text].
|
| 6.
|
Burley, S. K., and R. G. Roeder.
1996.
Biochemistry and structural biology of transcription factor IID (TFIID).
Annu. Rev. Biochem.
65:769-799[CrossRef][Medline].
|
| 7.
|
Chiang, C. M.,
H. Ge,
Z. Wang,
A. Hoffmann, and R. G. Roeder.
1993.
Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III.
EMBO J.
12:2749-2762[Medline].
|
| 8.
|
Cho, E. J.,
T. Takagi,
C. R. Moore, and S. Buratowski.
1997.
mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain.
Genes Dev.
11:3319-3326[Abstract/Free Full Text].
|
| 9.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 10.
|
Dantonel, J. C.,
K. G. Murthy,
J. L. Manley, and L. Tora.
1997.
Transcription factor TFIID recruits factor CPSF for formation of 3' end of mRNA.
Nature
389:399-402[CrossRef][Medline].
|
| 11.
|
Dantonel, J. C.,
J. M. Wurtz,
O. Poch,
D. Moras, and L. Tora.
1999.
The TBP-like factor: an alternative transcription factor in metazoa?
Trends Biochem. Sci.
24:335-339[CrossRef][Medline].
|
| 12.
|
Fondell, J. D.,
M. Guermah,
S. Malik, and R. G. Roeder.
1999.
Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID.
Proc. Natl. Acad. Sci. USA
96:1959-1964[Abstract/Free Full Text].
|
| 13.
|
Gossen, M., and H. Bujard.
1992.
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Proc. Natl. Acad. Sci. USA
89:5547-5551[Abstract/Free Full Text].
|
| 14.
|
Grant, P. A.,
D. Schieltz,
M. G. Pray-Grant,
D. J. Steger,
J. C. Reese,
J. R. Yates, 3rd, and J. L. Workman.
1998.
A subset of TAF(II)s are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation.
Cell
94:45-53[CrossRef][Medline].
|
| 15.
|
Grant, P. A.,
D. E. Sterner,
L. J. Duggan,
J. L. Workman, and S. L. Berger.
1998.
The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes.
Trends Cell Biol.
8:193-197[CrossRef][Medline].
|
| 16.
|
Hahn, S.
1998.
The role of TAFs in RNA polymerase II transcription.
Cell
95:579-582[CrossRef][Medline].
|
| 17.
|
Harlow, E., and D. Lane.
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 18.
|
Hernandez, N.
1993.
TBP, a universal eukaryotic transcription factor?
Genes Dev.
7:1291-1308[Free Full Text].
|
| 19.
|
Hirose, Y., and J. L. Manley.
1998.
RNA polymerase II is an essential mRNA polyadenylation factor.
Nature
395:93-96[CrossRef][Medline].
|
| 20.
|
Hisatake, K.,
T. Ohta,
R. Takada,
M. Guermah,
M. Horikoshi,
Y. Nakatani, and R. G. Roeder.
1995.
Evolutionary conservation of human TATA-binding-polypeptide-associated factors TAFII31 and TAFII80 and interactions of TAFII80 with other TAFs and with general transcription factors.
Proc. Natl. Acad. Sci. USA
92:8195-8199[Abstract/Free Full Text].
|
| 21.
|
Hockenbery, D.,
G. Nunez,
C. Milliman,
R. D. Schreiber, and S. J. Korsmeyer.
1990.
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
Nature
348:334-336[CrossRef][Medline].
|
| 22.
|
Holstege, F. C.,
E. G. Jennings,
J. J. Wyrick,
T. I. Lee,
C. J. Hengartner,
M. R. Green,
T. R. Golub,
E. S. Lander, and R. A. Young.
1998.
Dissecting the regulatory circuitry of a eukaryotic genome.
Cell
95:717-728[CrossRef][Medline].
|
| 23.
|
Ito, M.,
C. X. Yuan,
S. Malik,
W. Gu,
J. D. Fondell,
S. Yamamura,
Z. Y. Fu,
X. Zhang,
J. Qin, and R. G. Roeder.
1999.
Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.
Mol. Cell
3:361-370[CrossRef][Medline].
|
| 24.
|
Jacq, X.,
C. Brou,
Y. Lutz,
I. Davidson,
P. Chambon, and L. Tora.
1994.
Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor.
Cell
79:107-117[CrossRef][Medline].
|
| 25.
|
Kadonaga, J. T.
1998.
Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines.
Cell
92:307-313[CrossRef][Medline].
|
| 26.
|
Kimura, H.,
Y. Tao,
R. G. Roeder, and P. R. Cook.
1999.
Quantitation of RNA polymerase II and its transcription factors in an HeLa cell: little soluble holoenzyme but significant amounts of polymerases attached to the nuclear substructure.
Mol. Cell. Biol.
19:5383-5392[Abstract/Free Full Text].
|
| 27.
|
Koleske, A. J., and R. A. Young.
1994.
An RNA polymerase II holoenzyme responsive to activators.
Nature
368:466-469[CrossRef][Medline].
|
| 28.
|
Komarnitsky, P. B.,
B. Michel, and S. Buratowski.
1999.
TFIID-specific yeast TAF40 is essential for the majority of RNA polymerase II-mediated transcription in vivo.
Genes Dev.
13:2484-2489[Abstract/Free Full Text].
|
| 29.
|
Kuras, L., and K. Struhl.
1999.
Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme.
Nature
399:609-613[CrossRef][Medline].
|
| 30.
|
Lee, T. I., and R. A. Young.
1998.
Regulation of gene expression by TBP-associated proteins.
Genes Dev.
12:1398-1408[Free Full Text].
|
| 31.
|
Li, F.,
G. Ambrosini,
E. Y. Chu,
J. Plescia,
S. Tognin,
P. C. Marchisio, and D. C. Altieri.
1998.
Control of apoptosis and mitotic spindle checkpoint by survivin.
Nature
396:580-584[CrossRef][Medline].
|
| 32.
|
Li, X. Y.,
A. Virbasius,
X. Zhu, and M. R. Green.
1999.
Enhancement of TBP binding by activators and general transcription factors.
Nature
399:605-609[CrossRef][Medline].
|
| 33.
|
Martinez, E.,
H. Ge,
Y. Tao,
C. X. Yuan,
V. Palhan, and R. G. Roeder.
1998.
Novel cofactors and TFIIA mediate functional core promoter selectivity by the human TAFII150-containing TFIID complex.
Mol. Cell. Biol.
18:6571-6583[Abstract/Free Full Text].
|
| 34.
|
Martinez, E.,
T. K. Kundu,
J. Fu, and R. G. Roeder.
1998.
A human SPT3-TAFII31-GCN5-L acetylase complex distinct from transcription factor IID.
J. Biol. Chem.
273:23781-23785[Abstract/Free Full Text].
|
| 35.
|
McCracken, S.,
N. Fong,
E. Rosonina,
K. Yankulov,
G. Brothers,
D. Siderovski,
A. Hessel,
S. Foster,
S. Shuman, and D. L. Bentley.
1997.
5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II.
Genes Dev.
11:3306-3318[Abstract/Free Full Text].
|
| 36.
|
McCracken, S.,
N. Fong,
K. Yankulov,
S. Ballantyne,
G. Pan,
J. Greenblatt,
M. Patterson,
S. D. Wickens, and D. L. Bentley.
1997.
The C-terminal domain of RNA polymerase II couples mRNA processing to transcription.
Nature
385:357-361[CrossRef][Medline].
|
| 37.
|
Metzger, D.,
E. Scheer,
A. Soldatov, and L. Tora.
1999.
Mammalian TAF(II)30 is required for cell cycle progression and specific cellular differentiation programmes.
EMBO J.
18:4823-4834[CrossRef][Medline].
|
| 38.
|
Michel, B.,
P. Komarnitsky, and S. Buratowski.
1998.
Histone-like TAFs are essential for transcription in vivo.
Mol. Cell
2:663-673[CrossRef][Medline].
|
| 39.
|
Moqtaderi, Z.,
Y. Bai,
D. Poon,
P. A. Weil, and K. Struhl.
1996.
TBP-associated factors are not generally required for transcriptional activation in yeast.
Nature
383:188-191[CrossRef][Medline].
|
| 40.
|
Moqtaderi, Z.,
M. Keaveney, and K. Struhl.
1998.
The histone H3-like TAF is broadly required for transcription in yeast.
Mol. Cell
2:675-682[CrossRef][Medline].
|
| 41.
|
Naar, A. M.,
P. A. Beaurang,
S. Zhou,
S. Abraham,
W. Solomon, and R. Tjian.
1999.
Composite co-activator ARC mediates chromatin-directed transcriptional activation.
Nature
398:828-832[CrossRef][Medline].
|
| 42.
|
Natarajan, K.,
B. M. Jackson,
E. Rhee, and A. G. Hinnebusch.
1998.
yTAFII61 has a general role in RNA polymerase II transcription and is required by Gcn4p to recruit the SAGA coactivator complex.
Mol. Cell
2:683-692[CrossRef][Medline].
|
| 43.
|
Oelgeschlager, T.,
Y. Tao,
Y. K. Kang, and R. G. Roeder.
1998.
Transcription activation via enhanced preinitiation complex assembly in a human cell-free system lacking TAFIIs.
Mol. Cell
1:925-931[CrossRef][Medline].
|
| 44.
|
Ogryzko, V. V.,
T. Kotani,
X. Zhang,
R. L. Schlitz,
T. Howard,
X. J. Yang,
B. H. Howard,
J. Qin, and Y. Nakatani.
1998.
Histone-like TAFs within the PCAF histone acetylase complex.
Cell
94:35-44[CrossRef][Medline].
|
| 45.
|
Orphanides, G.,
T. Lagrange, and D. Reinberg.
1996.
The general transcription factors of RNA polymerase II.
Genes Dev.
10:2657-2683[Free Full Text].
|
| 46.
|
Rachez, C.,
B. D. Lemon,
Z. Suldan,
V. Bromleigh,
M. Gamble,
A. M. Naar,
H. Erdjument-Bromage,
P. Tempst, and L. P. Freedman.
1999.
Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.
Nature
398:824-828[CrossRef][Medline].
|
| 47.
|
Ryu, S.,
S. Zhou,
A. G. Ladurner, and R. Tjian.
1999.
The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1.
Nature
397:446-450[CrossRef][Medline].
|
| 48.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 49.
|
Sanders, S. L.,
E. R. Klebanow, and P. A. Weil.
1999.
TAF25p, a non-histone-like subunit of TFIID and SAGA complexes, is essential for total mRNA gene transcription in vivo.
J. Biol. Chem.
274:18847-18850[Abstract/Free Full Text].
|
| 50.
|
Sauer, F., and R. Tjian.
1997.
Mechanisms of transcriptional activation: differences and similarities between yeast, Drosophila, and man.
Curr. Opin. Genet. Dev.
7:176-181[CrossRef][Medline].
|
| 51.
|
Schaeffer, V.,
F. Janody,
C. Loss,
C. Desplan, and E. A. Wimmer.
1999.
Bicoid functions without its TATA-binding protein-associated factor interaction domains.
Proc. Natl. Acad. Sci. USA
96:4461-4466[Abstract/Free Full Text].
|
| 52.
|
Shen, W. C., and M. R. Green.
1997.
Yeast TAF(II)145 functions as a core promoter selectivity factor, not a general coactivator.
Cell
90:615-624[CrossRef][Medline].
|
| 53.
|
Soldatov, A.,
E. Nabirochkina,
S. Georgieva,
T. Belenkaja, and P. Georgiev.
1999.
TAFII40 protein is encoded by the e(y)1 gene: biological consequences of mutations.
Mol. Cell. Biol.
19:3769-3778[Abstract/Free Full Text].
|
| 54.
|
Sterner, D. E.,
P. A. Grant,
S. M. Roberts,
L. J. Duggan,
R. Belotserkovskaya,
L. A. Pacella,
F. Winston,
J. L. Workman, and S. L. Berger.
1999.
Functional organization of the yeast SAGA complex: distinct components involved in structural integrity, nucleosome acetylation, and TATA-binding protein interaction.
Mol. Cell. Biol.
19:86-98[Abstract/Free Full Text].
|
| 55.
|
Struhl, K., and Z. Moqtaderi.
1998.
The TAFs in the HAT.
Cell
94:1-4[CrossRef][Medline].
|
| 56.
|
Sun, X.,
Y. Zhang,
H. Cho,
P. Rickert,
E. Lees,
W. Lane, and D. Reinberg.
1998.
NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription.
Mol. Cell
2:213-222[CrossRef][Medline].
|
| 57.
|
Suzuki-Yagawa, Y.,
M. Guermah, and R. G. Roeder.
1997.
The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.
Mol. Cell. Biol.
17:3284-3294[Abstract].
|
| 58.
|
Takagaki, Y., and J. L. Manley.
1998.
Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation.
Mol. Cell
2:761-771[CrossRef][Medline].
|
| 59.
|
Tansey, W. P., and W. Herr.
1997.
TAFs: guilt by association?
Cell
88:729-732[CrossRef][Medline].
|
| 60.
|
Tao, Y.,
M. Guermah,
E. Martinez,
T. Oelgeschlager,
S. Hasegawa,
R. Takada,
T. Yamamoto,
M. Horikoshi, and R. G. Roeder.
1997.
Specific interactions and potential functions of human TAFII100.
J. Biol. Chem.
272:6714-6721[Abstract/Free Full Text].
|
| 61.
|
Treisman, R.
1994.
Ternary complex factors: growth factor regulated transcriptional activators.
Curr. Opin. Genet. Dev.
4:96-101[CrossRef][Medline].
|
| 62.
|
Verrijzer, C. P., and R. Tjian.
1996.
TAFs mediate transcriptional activation and promoter selectivity.
Trends Biochem. Sci.
21:338-342[CrossRef][Medline].
|
| 63.
|
Walker, S. S.,
J. C. Reese,
L. M. Apone, and M. R. Green.
1996.
Transcription activation in cells lacking TAFIIS.
Nature
383:185-188[CrossRef][Medline].
|
| 64.
|
Walker, S. S.,
W. C. Shen,
J. C. Reese,
L. M. Apone, and M. R. Green.
1997.
Yeast TAF(II)145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state.
Cell
90:607-614[CrossRef][Medline].
|
| 65.
|
Wang, J.,
Y. Takagaki, and J. L. Manley.
1996.
Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.
Genes Dev.
10:2588-2599[Abstract/Free Full Text].
|
| 66.
|
Wang, E. H., and R. Tjian.
1994.
Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250.
Science
263:811-814[Abstract/Free Full Text].
|
| 67.
|
Wieczorek, E.,
M. Brand,
X. Jacq, and L. Tora.
1998.
Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.
Nature
393:187-191[CrossRef][Medline].
|
| 68.
|
Wu, S. Y.,
E. Kershnar, and C. M. Chiang.
1998.
TAFII-independent activation mediated by human TBP in the presence of the positive cofactor PC4.
EMBO J.
17:4478-4490[CrossRef][Medline].
|
| 69.
|
Yue, Z.,
E. Maldonado,
R. Pillutla,
H. Cho,
D. Reinberg, and A. J. Shatkin.
1997.
Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II.
Proc. Natl. Acad. Sci. USA
94:12898-12903[Abstract/Free Full Text].
|
| 70.
|
Zhou, J.,
J. Zwicker,
P. Szymanski,
M. Levine, and R. Tjian.
1998.
TAFII mutations disrupt Dorsal activation in the Drosophila embryo.
Proc. Natl. Acad. Sci. USA
95:13483-13488[Abstract/Free Full Text].
|
Molecular and Cellular Biology, July 2000, p. 5064-5076, Vol. 20, No. 14
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Li, X., Niu, T., Manley, J. L.
(2007). The RNA binding protein RNPS1 alleviates ASF/SF2 depletion-induced genomic instability. RNA
13: 2108-2115
[Abstract]
[Full Text]
-
Muller, F., Demeny, M. A., Tora, L.
(2007). New Problems in RNA Polymerase II Transcription Initiation: Matching the Diversity of Core Promoters with a Variety of Promoter Recognition Factors. J. Biol. Chem.
282: 14685-14689
[Full Text]
-
Li, X., Wang, J., Manley, J. L.
(2005). Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev.
19: 2705-2714
[Abstract]
[Full Text]
-
Frontini, M., Soutoglou, E., Argentini, M., Bole-Feysot, C., Jost, B., Scheer, E., Tora, L.
(2005). TAF9b (Formerly TAF9L) Is a Bona Fide TAF That Has Unique and Overlapping Roles with TAF9. Mol. Cell. Biol.
25: 4638-4649
[Abstract]
[Full Text]
-
Chen, Z., Manley, J. L.
(2003). Core Promoter Elements and TAFs Contribute to the Diversity of Transcriptional Activation in Vertebrates. Mol. Cell. Biol.
23: 7350-7362
[Abstract]
[Full Text]
-
Chen, Z., Manley, J. L.
(2003). In Vivo Functional Analysis of the Histone 3-like TAF9 and a TAF9-related Factor, TAF9L. J. Biol. Chem.
278: 35172-35183
[Abstract]
[Full Text]
-
Wu, S.-Y., Zhou, T., Chiang, C.-M.
(2003). Human Mediator Enhances Activator-Facilitated Recruitment of RNA Polymerase II and Promoter Recognition by TATA-Binding Protein (TBP) Independently of TBP-Associated Factors. Mol. Cell. Biol.
23: 6229-6242
[Abstract]
[Full Text]
-
Hochheimer, A., Tjian, R.
(2003). Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. Genes Dev.
17: 1309-1320
[Full Text]
-
Kashiwabara, S.-i., Noguchi, J., Zhuang, T., Ohmura, K., Honda, A., Sugiura, S., Miyamoto, K., Takahashi, S., Inoue, K., Ogura, A., Baba, T.
(2002). Regulation of Spermatogenesis by Testis-Specific, Cytoplasmic Poly(A) Polymerase TPAP. Science
298: 1999-2002
[Abstract]
[Full Text]
-
Thuault, S., Gangloff, Y.-G., Kirchner, J., Sanders, S., Werten, S., Romier, C., Weil, P. A., Davidson, I.
(2002). Functional Analysis of the TFIID-specific Yeast TAF4 (yTAFII48) Reveals an Unexpected Organization of Its Histone-fold Domain. J. Biol. Chem.
277: 45510-45517
[Abstract]
[Full Text]
-
Gangloff, Y.-G., Pointud, J.-C., Thuault, S., Carre, L., Romier, C., Muratoglu, S., Brand, M., Tora, L., Couderc, J.-L., Davidson, I.
(2001). The TFIID Components Human TAFII140 and Drosophila BIP2 (TAFII155) Are Novel Metazoan Homologues of Yeast TAFII47 Containing a Histone Fold and a PHD Finger. Mol. Cell. Biol.
21: 5109-5121
[Abstract]
[Full Text]
-
Um, M., Yamauchi, J., Kato, S., Manley, J. L.
(2001). Heterozygous Disruption of the TATA-Binding Protein Gene in DT40 Cells Causes Reduced cdc25B Phosphatase Expression and Delayed Mitosis. Mol. Cell. Biol.
21: 2435-2448
[Abstract]
[Full Text]
-
Tsukihashi, Y., Kawaichi, M., Kokubo, T.
(2001). Requirement for Yeast TAF145 Function in Transcriptional Activation of the RPS5 Promoter That Depends on Both Core Promoter Structure and Upstream Activating Sequences. J. Biol. Chem.
276: 25715-25726
[Abstract]
[Full Text]
-
Wu, S.-Y., Chiang, C.-M.
(2001). TATA-binding Protein-associated Factors Enhance the Recruitment of RNA Polymerase II by Transcriptional Activators. J. Biol. Chem.
276: 34235-34243
[Abstract]
[Full Text]